DCF — SANFORD ABERDEEN MEDICAL CENTER
Enterprise Value: $-56.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-56.6M
Enterprise Value
$-18.9M
PV of Cash Flows
$-37.7M
PV of Terminal Value
$-60.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $65.9M | $-3.0M | -5.0% | $-5.8M | $-5.2M |
| Year 2 | $67.9M | $-2.4M | -4.0% | $-5.2M | $-4.3M |
| Year 3 | $69.9M | $-1.7M | -3.0% | $-4.7M | $-3.5M |
| Year 4 | $72.0M | $-1.4M | -2.0% | $-4.5M | $-3.1M |
| Year 5 | $74.2M | $-1.3M | -2.0% | $-4.4M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-56.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$64.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000002344173525
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5